Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Rowland

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical and Hospital Pharmacy|March 1, 1985
Cost-benefit analysis of clinical pharmacy services in three Iowa family practice officesE A Chrischilles, D K Helling, C R Rowland
Medical Interface|March 9, 1995
Economic costs of obsessive-compulsive disorderR L DuPont, D P Rice, S Shiraki, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 1, 1976
Economic cost of pulmonary emphysema: implications for policy on smoking and healthR A Freeman, C R Rowland, M C Smith, et al.
Clinical Therapeutics|February 24, 2001
Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptanS S Colman, M I Brod, A Krishnamurthy, et al.
Archives of Neurology|June 19, 2001
Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparisonE L Spierings, B Gomez-Mancilla, D E Grosz, et al.
Anxiety|January 1, 1996
Economic costs of anxiety disordersR L DuPont, D P Rice, L S Miller, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical and Hospital Pharmacy|March 1, 1985
Cost-benefit analysis of clinical pharmacy services in three Iowa family practice officesE A Chrischilles, D K Helling, C R Rowland
Medical Interface|March 9, 1995
Economic costs of obsessive-compulsive disorderR L DuPont, D P Rice, S Shiraki, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 1, 1976
Economic cost of pulmonary emphysema: implications for policy on smoking and healthR A Freeman, C R Rowland, M C Smith, et al.
Clinical Therapeutics|February 24, 2001
Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptanS S Colman, M I Brod, A Krishnamurthy, et al.
Archives of Neurology|June 19, 2001
Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparisonE L Spierings, B Gomez-Mancilla, D E Grosz, et al.
Anxiety|January 1, 1996
Economic costs of anxiety disordersR L DuPont, D P Rice, L S Miller, et al.
Pageof 2